United States
Ackman's Pershing Square makes $3.3 billion bet on Valeant
Billionaire investor William Ackman has purchased a five percent stake in Valeant Pharmaceuticals (VRX.TO) (VRX.N), his hedge fund said on Monday, making him the Canadian drug company's fifth-largest stakeholder.
Wall St. rebounds on deal activity; Apple up after watch news
U.S. stocks bounced back on Monday, helped by merger and acquisitions activity, while Apple shares ended slightly higher following the long-anticipated rollout of its watch.
Starboard urges Yahoo to buy back up to $4 billion of shares
Yahoo Inc shareholder Starboard Value LP said the company's spinoff of its stake in Alibaba Group Holding Ltd was a "good first step" but it could do more, including a share buyback of up to $4 billion.
Concordia Healthcare to buy some assets of Covis Pharma for $1.2 billion
Concordia Healthcare Corp (CXR.TO), which makes drugs for rare diseases and devices for diabetic patients, said it would buy some assets of privately held Covis Pharma Holdings SARL for $1.2 billion in cash.